217 related articles for article (PubMed ID: 23390919)
1. [Effects of Imipenem, Tobramycin and Curcumin on Biofilm Formation of Pseudomonas aeruginosa Strains].
Karaman M; Fırıncı F; Arıkan Ayyıldız Z; Bahar IH
Mikrobiyol Bul; 2013 Jan; 47(1):192-4. PubMed ID: 23390919
[TBL] [Abstract][Full Text] [Related]
2. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746
[No Abstract] [Full Text] [Related]
3. In vitro activity of clarithromycin in combination with other antimicrobial agents against biofilm-forming Pseudomonas aeruginosa strains.
Kádár B; Szász M; Kristóf K; Pesti N; Krizsán G; Szentandrássy J; Rókusz L; Nagy K; Szabó D
Acta Microbiol Immunol Hung; 2010 Sep; 57(3):235-45. PubMed ID: 20870595
[TBL] [Abstract][Full Text] [Related]
4. Resistance of artificial biofilms of Pseudomonas aeruginosa to imipenem and tobramycin.
Coquet L; Junter GA; Jouenne T
J Antimicrob Chemother; 1998 Dec; 42(6):755-60. PubMed ID: 10052899
[TBL] [Abstract][Full Text] [Related]
5. In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection.
Hengzhuang W; Wu H; Ciofu O; Song Z; Høiby N
Antimicrob Agents Chemother; 2012 May; 56(5):2683-90. PubMed ID: 22354300
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells.
Yu Q; Griffin EF; Moreau-Marquis S; Schwartzman JD; Stanton BA; O'Toole GA
J Antimicrob Chemother; 2012 Nov; 67(11):2673-81. PubMed ID: 22843834
[TBL] [Abstract][Full Text] [Related]
7.
Roizman D; Vidaillac C; Givskov M; Yang L
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760898
[TBL] [Abstract][Full Text] [Related]
8. The effect of tobramycin incorporated with bismuth-ethanedithiol loaded on niosomes on the quorum sensing and biofilm formation of Pseudomonas aeruginosa.
Mahdiun F; Mansouri S; Khazaeli P; Mirzaei R
Microb Pathog; 2017 Jun; 107():129-135. PubMed ID: 28323149
[TBL] [Abstract][Full Text] [Related]
9. Determining effects of nitrate, arginine, and ferrous on antibiotic recalcitrance of clinical strains of Pseudomonas aeruginosa in biofilm-inspired alginate encapsulates.
Jabalameli F; Emaneini M; Beigverdi R; Halimi S; Siroosi M
Ann Clin Microbiol Antimicrob; 2023 Jul; 22(1):61. PubMed ID: 37475017
[TBL] [Abstract][Full Text] [Related]
10. In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients.
Fernández-Olmos A; García-Castillo M; Maiz L; Lamas A; Baquero F; Cantón R
Int J Antimicrob Agents; 2012 Aug; 40(2):173-6. PubMed ID: 22727530
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms.
Armijo LM; Wawrzyniec SJ; Kopciuch M; Brandt YI; Rivera AC; Withers NJ; Cook NC; Huber DL; Monson TC; Smyth HDC; Osiński M
J Nanobiotechnology; 2020 Feb; 18(1):35. PubMed ID: 32070354
[TBL] [Abstract][Full Text] [Related]
12. Synergistic activity of sub-inhibitory concentrations of curcumin with ceftazidime and ciprofloxacin against Pseudomonas aeruginosa quorum sensing related genes and virulence traits.
Roudashti S; Zeighami H; Mirshahabi H; Bahari S; Soltani A; Haghi F
World J Microbiol Biotechnol; 2017 Mar; 33(3):50. PubMed ID: 28188589
[TBL] [Abstract][Full Text] [Related]
13. Sub-minimum inhibitory concentrations of ceftazidime inhibit Pseudomonas aeruginosa biofilm formation.
Otani S; Hiramatsu K; Hashinaga K; Komiya K; Umeki K; Kishi K; Kadota JI
J Infect Chemother; 2018 Jun; 24(6):428-433. PubMed ID: 29449129
[TBL] [Abstract][Full Text] [Related]
14. Comparison of inhibitory and bactericidal activity of antipseudomonal antibiotics against Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Ansorg R; Müller KD; Wiora J
Chemotherapy; 1990; 36(3):222-9. PubMed ID: 2110878
[TBL] [Abstract][Full Text] [Related]
15. Synergistic interaction of cuminaldehyde and tobramycin: a potential strategy for the efficient management of biofilm caused by Pseudomonas aeruginosa.
Chatterjee S; Das S; Paul P; Chakraborty P; Sarkar S; Das A; Tribedi P
Folia Microbiol (Praha); 2023 Feb; 68(1):151-163. PubMed ID: 36192618
[TBL] [Abstract][Full Text] [Related]
16. Analyzing the Activity of Micafungin Combined with Tobramycin Against Pseudomonas Aeruginosa Biofilm.
Li YH; Zhang SX; Yang Y; Wang TY; Zheng JX
Clin Lab; 2023 Jun; 69(6):. PubMed ID: 37307133
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].
Coban AY; Ciftci A; Onuk EE; Erturan Z; Tanriverdi Cayci Y; Durupinar B
Mikrobiyol Bul; 2009 Oct; 43(4):563-73. PubMed ID: 20084909
[TBL] [Abstract][Full Text] [Related]
18. Relationship between antibiotic resistance, biofilm formation, genes coding virulence factors and source of origin of
Ratajczak M; Kamińska D; Nowak-Malczewska DM; Schneider A; Dlugaszewska J
Ann Agric Environ Med; 2021 Jun; 28(2):306-313. PubMed ID: 34184515
[TBL] [Abstract][Full Text] [Related]
19. PEGylation of Tobramycin Improves Mucus Penetration and Antimicrobial Activity against Pseudomonas aeruginosa Biofilms in Vitro.
Bahamondez-Canas TF; Zhang H; Tewes F; Leal J; Smyth HDC
Mol Pharm; 2018 Apr; 15(4):1643-1652. PubMed ID: 29514003
[TBL] [Abstract][Full Text] [Related]
20. An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections.
Koeva M; Gutu AD; Hebert W; Wager JD; Yonker LM; O'Toole GA; Ausubel FM; Moskowitz SM; Joseph-McCarthy D
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
